Key Republican urges Biden to set broad restrictions on U.S. investments in China

By David Shepardson WASHINGTON (Reuters) – The chair of a U.S. House committee on Thursday urged President Joe Biden to adopt expansive restrictions on outbound U.S. investment in China especially in key sectors likely to harm U.S. national security. Representative Mike Gallagher, a Republican who heads the select committee on China, wants the Biden administration…

Read More

Walgreens sells $1.85 billion of AmerisourceBergen shares, further cutting stake

(Reuters) – Walgreens Boots Alliance has sold some AmerisourceBergen Corp’s shares for proceeds of about $1.85 billion, the U.S. drugstore chain said on Thursday, further cutting its ownership in the drug distributor to about 16%. Walgreens said in a statement it would use the proceeds to pay down debt and for general corporate purposes. The…

Read More

Ukraine’s Zelenskiy decries ‘revolting’ practices at recruitment centres

(Reuters) – President Volodymyr Zelenskiy on Thursday decried “revolting” practices exposed during an audit of Ukraine’s military recruitment centres and pledged to fix the system by placing in charge people who understood the meaning of war. Zelenskiy has expressed indignation at corruption uncovered during the audit last month after a high-profile incident of wrongdoing came…

Read More

Subpoenas possible for BlackRock, MSCI over China investments -US House panel chair

By Michael Martina and Patricia Zengerle WASHINGTON (Reuters) -The chairman of a U.S. congressional committee on China held out the possibility on Thursday of subpoenas for executives from asset management firm BlackRock and index provider MSCI if they do not provide “fulsome” answers about investments in blacklisted Chinese companies. The House of Representatives select committee…

Read More

US CDC panel recommends Sanofi-AstraZeneca’s preventive RSV therapy for babies

(Reuters) -The U.S. Centers for Disease Control and Prevention (CDC) said its advisory panel on Thursday recommended use of Sanofi and partner AstraZeneca’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers. The Advisory Committee on Immunization Practices unanimously recommended nirsevimab for preventing lower respiratory tract disease in newborns and infants below…

Read More